Case Studies
These case studies show how healthcare changes when employers move beyond annual renewals and begin treating the plan as a financial system.
Each case reflects a specific context, set of decisions, and outcome.
They are not guarantees or prescriptions. They are examples of what becomes visible when structure, incentives, and governance are examined more carefully.
Erie Manufacturer: Governing Specialty Drug Spend
A 350-employee manufacturer faced escalating specialty drug costs despite traditional renewal strategies.
By treating prescription drug spending as a system requiring visibility and governance, the employer achieved more than $1.67 million in specialty drug savings over three years.
Themes: Prescription drug transparency, specialty drug governance, financial structure
GLI Pool Products: Changing the Healthcare Cost Trajectory
GLI Pool Products moved from a fully insured status quo arrangement to a more deliberate structure beginning in 2015.
Over time, the company’s actual healthcare costs tracked below benchmark trend assumptions, resulting in $8.86 million in cumulative savings through 2020.
Themes: Long-term cost trajectory, independent plan governance, growth-stage healthcare strategy